DAVIS—Medical entomologist Gregory Lanzaro, director of the University of California Mosquito Research Program and the UC Davis Center for Vectorborne Diseases, based at the School of Veterinary Medicine, has received a four-year $1.3 million grant from the National Institutes of Health to study the role of saliva in a blood-sucking sand fly that transmits the deadly parasitic disease, visceral leishmaniasis (VL). This is the first-ever study focusing on the effects of sand fly salivary proteins on VL, also known as kala azar or “black fever,” Lanzaro said. The Leismania parasites, transmitted by infected female sand flies, attack the internal organs, including the spleen and liver. “The disease is almost always fatal unless treated,” he said.
Previous studies on sand fly saliva have targeted the more common cutaneous leishmaniasis (CL), characterized by skin lesions that result in permanent scarring, but is rarely fatal. Globally, an estimated 500,000 new cases of VL and 1.5 million cases of CL occur annually. World Health Organization statistics indicate that leishmaniasis infects 12 million people, but more than 350 million people in 88 countries, primarily tropical and sub-tropical, are at risk. In the
Salivary proteins affect the blood flow and modulate the immune response of the host. Of special interest is the salivary protein, maxidilan, which suppresses white blood cells that destroy the invading parasites.
Lanzaro and his research team are targeting Leishmania chagasi, a New World parasite that causes VL in the
Co-principal investigator is Lynn Soong, an associate professor, Department of Microbiology and Immunology,
Stephen Barthold, director of the Center for Comparative Medicine, UC Davis School of Veterinary Medicine and a veterinary pathologist with 35 years of experience in experimental pathology of infectious diseases, is a collaborator. Others working on the grant include Peter Melby of the University of Texas Health Sciences Center; assistant specialist
Lanzaro said the disease can cause large-scale epidemics with high fatality rates. More than 90 percent of the world's cases of VL are in
The Leishmania parasite incubates for weeks to months in the host before the disease becomes clinically apparent. Symptoms of VL include bouts of fever, hemorrhaging, weight loss, swollen glands, anemia and darkening of the skin.
Leishmaniasis usually is more common in rural areas, Lanzaro said, but it is found in the outskirts of some cities. The risk for leishmaniasis is highest from dusk to dawn, when sand flies are the most active. At increased risk are military, adventure travelers, Peace Corps volunteers, missionaries, ornithologists and researchers who work outdoors at night.
How to Decrease the Risk of Getting Leishmaniasis
Vaccines and drugs for preventing leishmaniasis, a parasitic disease spread by the bite of infected sand flies, are not yet available, so it’s important to “know the enemy” and take precautions, says UC Davis medical entomologist Gregory Lanzaro.
Sand flies are about one-third the size of mosquitoes. They are difficult to see and make no noise when they fly. The insects become infected by biting an infected dog, rodent or person.
Cutaneous leishmaniasis (CL), characterized by skin lesions resulting in permanent scarring, is found in parts of 88 countries, including the
Symptoms of CL (skin sores) usually appear within a few weeks after the sand fly bite. With VL, people usually become sick within several months of being bitten.
To decrease the risk of being bitten by sand flies:
Media contact:
Kathy Keatley Garvey, UC Statewide Mosquito Research Program, (530) 754-6894
This press release was originally distributed June 14, 2006 by the UC Statewide Mosquito Research Program.